Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report

BACKGROUND: Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through growth hormone/insulin-like growth factor 1 modulation, while tamoxifen reduces ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirfakhraee, Sasan, Chan, Alberto V. Cabo, Ganji, Niloofar, Abramowitz, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082960/
https://www.ncbi.nlm.nih.gov/pubmed/33910628
http://dx.doi.org/10.1186/s13256-021-02792-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082960/
https://www.ncbi.nlm.nih.gov/pubmed/33910628
http://dx.doi.org/10.1186/s13256-021-02792-8

Ejemplares similares